Last Tuesday,a founder of a biotech company stormed into my office,clutching a bill of lading for API worth $500,000 that was stuck at Shanghai Customs.He thought he could just find any random company to handle it.A freight forwarder with the appropriate "authorizations" can handle it,but the goods face the risk of being returned or destroyed because the agent lacks the "import" scope in the "Drug Trading License".In the field of pharmaceutical imports,"Being able to declare customs" and "compliant import" are two completely different concepts.Choosing the wrong agent not only results in financial losses,but also irreversible delays in market access opportunities.

Not All "Agents" are Created Equal: Hierarchical Mapping of Pharmaceutical Importers

Many purchasing managers,when looking for agents,often only focus on the quotations,but ignore the "value of the license" behind the agents.According to the regulations of the National Medical Products Administration (NMPA) and the General Administration of Customs,the division of roles in the pharmaceutical import chain is extremely strict.If you entrust the biologics that require cold chain transportation to an agent who only deals with ordinary chemical products,disaster is almost inevitable.

To help you quickly understand the current market situation,I’ve broken down the "imported pharmaceutical agents" currently available on the market into four tiers,and included a comparison of their risks and costs:

Practical process: How to verify your agent like an auditor

Don’t just listen to the verbal promises of sales staff.As a purchaser,you must establish a set of standard proceduresKYC (Know Your Customer)The process involves reverse auditing your service providers.Here’s the "Five-Dimensional Verification Method for Agent Qualifications" that I’ve summarized over the past 15 years.

Step 1: Conduct a penetrative verification of the Drug Trading License

Output:

Don’t just focus on whether the other person has a certificate.You should also check.as a registered business scopeThe license must explicitly include "Chemical pharmaceutical preparations/active pharmaceutical ingredients/biological productsOutput: "If your product is a biological product,but the other party only has a business scope for chemical drugs,this is a major problem.Require the other party to provide a copy of the license and check whether the ’Business Mode’ column includes ’Wholesale’."

Step 2: Verify compliance with the GSP (Good Storage Practice for Pharmaceutical Products) standards.

Output:

GSP is the lifeline of pharmaceutical distribution.Especially for products requiring cold chain storage,it is necessary to require the agent to provide information about their warehouse.Cold chain verification report.Focus on checking:

• Power-offInsulationDuration:Howlongcanacoldstoragemaintainatemperatureof2-8°Cafterapoweroutage?(Thestandardtypicallyrequiresatleast72hoursormore).
• TemperatureandHumidityMonitoringSystem:Doesithaveautomaticalarm,SMSnotification,andnon-modifiabledatarecordingfunctions?

Step 3: Confirm the registration relationship between the port and the Drug Administration Bureau

Output:

This is a detail that very few people outside the industry know about: imported drugs must be registered before they can be sold in China.Designated port of entryThe National Medical Products Administration conducts the filing of the "Import Drug Customs Clearance Form".If your agent is located in the north but insists on clearing customs through non-designated ports (such as ordinary bulk cargo ports),this usually means that they are trying to operate through gray channels,which carries extremely high risks.

Step 4: Capital stress test

Output:

The import of pharmaceuticals involves tariffs,value-added tax,and possible security deposits.If the agent requires you to prepay the tariffs in full,this might be a sign of their cash flow issues.Legitimate large-scale agents typically have credit lines,allowing them to advance the payment of tariffs and expedite the customs clearance process.

Expert Insight: The Overlooked "First-Time Order Information" - A Hidden Trap

Many companies think that the process ends once the goods arrive at the warehouse,but the real challenge actually lies elsewhere."First-time operation"Output: During the customs clearance process,I’ve encountered numerous cases where,after the goods are cleared,domestic sellers are unable to register the products in the system because the agent fails to provide complete foreign manufacturer’s notarization documents and authorization chains.As a result,the goods end up rotting in warehouses and can’t be sold.

When choosing an agent,a core question must be asked:"Are you responsible for organizing and uploading the complete set of first-time marketing materials to the Drug Administration Bureau’s platform?" A top-tier pharmaceutical agent is not just a transporter,but also your compliance manager.They should be familiar with the latest provisions of the Drug Administration Law.The requirements for notarization and certification of inspection reports.

Take action immediately: Today’s afternoon execution list

Don’t just bookmark this article and leave it unused.As a procurement or operations manager,please complete the following three tasks this afternoon:

• AuditExistingSuppliers:Findoutwhichpharmaceuticalcompanieswearecurrentlycooperatingwith.CheckwhethertheirDrugTradingLicenseisstillvalidandwhetheritsscopeofbusinessfullycoversyourcurrentproductline.
• SimulateColdChainBreakpoints:Ifyouareoperatingtemperature-controlledproducts,asktheagenttoprovideareportonabnormalwarehousetemperatureandhumidityrecordsforthepastthreemonths,andobservehowtheyhandlesuddentemperatureexceedingstandards.
• Signthecomplianceagreement:Itisclearlystipulatedinthecontractthatifthe"ImportDrugCustomsClearanceForm"failstobeprocessedduetotheagent’sincompletequalificationsoroperationalerrors,theagentshallbearallthedemurragefeesanddestructionfeescausedthereby.